SUDARSHAN PHARMA INDUSTRIES
Back to Balance Sheet
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹75 Cr | ₹77 Cr | ₹80 Cr | ₹27 Cr | ₹16 Cr |
What is the latest Net Current Assets ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹75 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹80 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹16 Cr |
How is Net Current Assets of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹75 Cr | -2.05 | |
| Mar2024 | ₹77 Cr | -4.26 | |
| Mar2023 | ₹80 Cr | 197.33 | |
| Mar2022 | ₹27 Cr | 64.14 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Current Assets of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹900.4 Cr | 6.1% | -13.4% | 14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 6.1% |
-13.4% |
14.2% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses